Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial)

The American Journal of Cardiology
Satish KenchaiahScott D Solomon

Abstract

Whether antecedent systemic hypertension influences the risk of subsequent left ventricular (LV) dilation in patients after an acute myocardial infarction with LV systolic dysfunction is unclear. We assessed echocardiographic evidence of ventricular remodeling from baseline (mean +/- SD 11 +/- 3 days) to 2 years after an acute myocardial infarction in 122 hypertensive (defined as a history of treated hypertension, baseline systolic blood pressure > or =140 or baseline diastolic blood pressure > or =90 mm Hg) and 334 nonhypertensive patients in the Survival and Ventricular Enlargement echocardiographic substudy. Compared with nonhypertensives, baseline heart size, defined as the sum of the average short- and long-axis LV cavity areas, was similar (70.1 +/- 11.9 vs 68.8 +/- 11.2 cm(2), p = 0.33 at end-diastole; 50.1 +/- 11.3 vs 48.8 +/- 10.8 cm(2), p = 0.31 at end-systole), but short-axis LV myocardial area (24.7 +/- 4.3 vs 25.7 +/- 5.0 cm(2), p = 0.043) and wall thickness (1.15 +/- 0.16 vs 1.21 +/- 0.17 cm, p = 0.004) at end-diastole were greater among hypertensives. The myocardial infarct segment lengths were similar in the 2 groups (p = 0.22). Although LV cavity areas increased significantly in the 2 groups from baseline to 2 ...Continue Reading

References

Apr 15, 1987·The American Journal of Cardiology·D LevyW P Castelli
Jul 14, 1988·The New England Journal of Medicine·M A PfefferE Braunwald
Nov 1, 1988·Journal of the American College of Cardiology·S E NolanH F Weisman
Aug 26, 1998·European Heart Journal·J S Alpert
Mar 30, 2002·Journal of the American College of Cardiology·A Mark RichardsJohn Turner
Mar 14, 2003·The American Journal of Cardiology·Hasan JilaihawiUNKNOWN Healing and Early Afterload Reducing Therapy Trial Investigators

❮ Previous
Next ❯

Citations

Nov 30, 2006·Current Heart Failure Reports·Jens Jakob Thune, Scott D Solomon
Sep 15, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Marc N BuscheGregory L Stahl
Jun 16, 2009·Canadian Journal of Physiology and Pharmacology·Claude LajoieAngelino Calderone
Oct 11, 2005·The American Journal of Cardiology·Alina GeorgescuUNKNOWN Assessment of the Safety and Efficacy of a New Thrombolytic Regimen Trial (ASSENT-3) Investigators
Oct 15, 2014·Clinical and Experimental Pharmacology & Physiology·Carla J WeinheimerAttila Kovacs
Sep 15, 2009·Molecular Immunology·W Brian GorsuchGregory L Stahl
Jan 22, 2005·Journal of Human Hypertension·E KazzamM G Nicholls
Oct 22, 2008·Experimental Brain Research·Sarah Pirio RichardsonMark Hallett
Jan 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Craig Evinger
Jan 21, 2016·Journal of Clinical Movement Disorders·Karlo J LizarragaCarlos Singer
Feb 21, 2008·Nature Reviews. Neuroscience·Xandra O BreakefieldDavid G Standaert
Jan 31, 2008·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Stéphane ThoboisEmmanuel Broussolle
Mar 23, 2011·Experimental Brain Research·Sandra Beck, Mark Hallett
Feb 10, 2012·Journal of Cardiovascular Medicine·Roberto PedrinelliUNKNOWN Gruppo di Studio Ipertensione e Cuore, Societa’ Italiana di Cardiologia
Jan 20, 2018·Scientific Reports·Yves-Alain KuhnWolfgang Taube
Aug 19, 2007·Journal of Cardiovascular Medicine·Alessandro PingitoreDaniele Rovai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.